Intuitive Surgical, Inc. $ISRG Stock Bought by One Way Holdings LLC

One Way Holdings LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 53.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,569 shares of the medical equipment provider’s stock after acquiring an additional 12,740 shares during the period. One Way Holdings LLC’s holdings in Intuitive Surgical were worth $14,870,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Intuitive Surgical in the second quarter valued at $14,316,000. Plato Investment Management Ltd bought a new stake in Intuitive Surgical in the 2nd quarter valued at $4,315,000. Hikari Power Ltd acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $5,619,000. NewEdge Advisors LLC raised its stake in shares of Intuitive Surgical by 19.1% in the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock valued at $20,212,000 after buying an additional 8,142 shares in the last quarter. Finally, Nykredit A S bought a new position in shares of Intuitive Surgical during the 2nd quarter worth about $48,464,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the director directly owned 251 shares in the company, valued at approximately $95,129. The trade was a 61.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 38,778 shares of company stock valued at $16,814,967 in the last ninety days. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $432.01 on Monday. The stock has a market cap of $149.75 billion, a P/E ratio of 52.24, a price-to-earnings-growth ratio of 2.98 and a beta of 1.45. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The stock has a 50 day simple moving average of $401.54 and a 200 day simple moving average of $434.05.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.40 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Wells Fargo & Company reaffirmed an “overweight” rating and set a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. Oppenheimer reiterated an “outperform” rating and set a $500.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 21st. Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. Finally, BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.